Found: 2
Select item for more details and to access through your institution.
Immunotherapy With Low-Dose IL-2/CD25 Prevents β-Cell Dysfunction and Dysglycemia in Prediabetic NOD Mice.
- Published in:
- Diabetes, 2023, v. 72, n. 6, p. 769, doi. 10.2337/db22-0482
- By:
- Publication type:
- Article
Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8+ T cells to enhance antitumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 4, p. 909, doi. 10.1007/s00262-020-02722-5
- By:
- Publication type:
- Article